Amalgamation of Astaxanthin and Spirulina may be a potential anti-carcinogenesis treatment strategy

Abstract

Introduction. A projected 43.8 million individuals die within five years of a diagnosis of cancer worldwide. For years, surgery, chemotherapy, radiation, and chemotherapy were the only options. For decades, surgery, immunotherapy, radiation, and chemotherapy were the only options. Numerous case studies demonstrate that micro-algae offer considerable potential as a cancer-fighting strategy. Frequent use of Astaxanthin, a red-colored antioxidant, combined with Spirulina, nutrient-rich blue-green algae, may show potential in cancer treatment. Objective. The major focus is on the mixture of astaxanthin and spirulina, two natural chemicals with anti-cancer capabilities against many malignancies. However, the combination of ATX with SPU is still in its early stages. Thus, we showed the anticancer capabilities from prior research and paved the way for the combination of these two compounds. Methodology. Various publications have been reviewed for evidence of these two chemicals' anticancer capabilities against different types of cancer, as well as how these compounds function against tumor tissues. Result. Individually, the therapeutic impact of spirulina can prevent HCC conformational alterations. Astaxanthin, on the other hand, is implicated in the prevention of prostate cancer in naked mice. Conclusion. This review might provide ideas for future cancer research or study into the combined therapeutic impact of these two natural anti-cancer agents.